Upstream Bio, Inc. ( UPB) - Stock Earnings
UPB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
UPB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -40.0 million USD | 937000 USD |
| 2025Q3 | -33.7 million USD | 683000 USD |
| 2025Q4 | -42.5 million USD | 668000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
UPB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.5 million USD | — USD |
| 2024 | -62.8 million USD | 2.4 million USD |
| 2025 | -143.4 million USD | 2.9 million USD |
| 2026 Est. | — | — |
UPB
Price: $2.76
52 week price:
Earnings Per Share: -6.31 USD
P/E Ratio: -1.22
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 274.3 million